Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 7, 2013, Pages 553-562

  Hanna, Jennifer ^a   Winstedt, Dag ^a   Schött, Ulf ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Blood coagulation; Factor XIII; Fibrinogen; Plasma albumin; Thromboelastography

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 13 CONCENTRATE; FIBRINOGEN CONCENTRATE;

ALBUMIN INDUCED COAGULOPATHY; ANALYZER; ARTICLE; BIOLOGICAL MONITORING; BLOOD CLOT; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CONTROLLED STUDY; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; HEMODILUTION; HUMAN; HUMAN EXPERIMENT; LABORATORY DEVICE; LOW DRUG DOSE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; ROTATIONAL THROMBOELASTOMETRY;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR XIII; FIBRINOGEN; HEMODILUTION; HUMANS; SERUM ALBUMIN; THROMBELASTOGRAPHY;

EID: 84885449674     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.821710     Document Type: Article

References (63)

1. Kang JG, Ahn HJ, K im G S, H ahm TS, L ee J J, G wak M S, Choi SJ. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4). Anesth Analg 2006 ; 103 : 1543 - 8. (Pubitemid 44949227)
2. Bolliger D, S zlam F, L evy JH, M olinaro RJ, T anaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010 ; 104 : 318-25.
3. Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005 ; 94 : 324-9. (Pubitemid 40352852)
4. Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011 ; 37 : 1725-37.
5. Levi M, J onge E. C linical relevance of the effects of plasma expanders on coagulation. Semin Thromb Hemost 2007 ; 33 : 810-5. (Pubitemid 351158449)
6. Marx G, S chuerholz T. F luid-induced coagulopathy: does the type of fluid make a difference? Crit Care 2010 ; 14 : 118.
7. Jungner M, Bentzer P, Grän de PO. I ntracranial pressure following resuscitation with albumin or saline in a cat model of meningitis. Crit Care Med 2011 ; 39 : 135-40.
8. Jungner M, Grän de PO, Mattiasson G, Bentzer P. Effects on brain edema of crystalloid and albumin fluid resuscitation after brain trauma and hemorrhage in the rat. Anesthesiology 2010 ; 112 : 1194-203.
9. Winstedt D, H anna J, S ch öt t U. A lbumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy. Scand J Clin Lab Invest 2013 ; 73 : 161-9.
10. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005 ; 49 : 1163-71. (Pubitemid 41192465)
11. Roche A M, James MF, Bennett-Guerrero E, Mythen MG. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 2006 ; 102 : 1274-9.
12. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005 ; 49 : 373-8. (Pubitemid 40432532)
13. Ekseth K, Abildgaard L, Vegfors M, Berg-Johnsen J, Engdahl O. The in vitro effects of crystalloids and colloids on coagulation. Anaesthesia 2002 ; 57 : 1102-8. (Pubitemid 35282559)
14. Niemi TT, Kuitunen A H. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998 ; 42 : 1104-9. (Pubitemid 28478132)
15. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012 ; 114 : 261-74.
16. Fries D, Martini W Z. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010 ; 105 : 116-21.
17. Haas T, Fries D, V elik-Salchner C, R eif C, K lingler A, Innerhofer P. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008 ; 106 : 1360-5. (Pubitemid 351571061)
18. Shenkman B, Livnat T, Lubetsky A, Tamarin I, Budnik I, Einav Y, Martinowitz U. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model. Blood Coagul Fibrinolysis 2012 ; 23 : 370-8.
19. Dirkmann D, Gorlinger K, Gisbertz C, Dusse F, Peters J. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg 2012 ; 114 : 1182-8.
20. Mutch NJ, Koikkalainen JS, Fraser SR, Duthie KM, Griffin M, Mitchell J, Watson HG, Booth NA. Model thrombi formed under flow reveal the role of factor XIIImediated cross-linking in resistance to fibrinolysis. J Thromb Haemost 2010 ; 8 : 2017-24.
21. Schramko A A, Kuitunen A H, Suojaranta-Ylinen RT, Niemi TT. Role of fibrinogen-, factor VIII- and XIIImediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand 2009 ; 53 : 731-5.
22. Sørensen B, Fries D. E merging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012 ; 99(Suppl. 1) : 40-50.
23. Howard B M, Daley AT, Cohen M J. Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions. Semin Thromb Hemost 2012 ; 38 : 250-8.
24. Maegele M, S pinella PC, Schöchl H. The acute coagulopathy of trauma: mechanisms and tools for risk stratification. Shock 2012 ; 38 : 450-8.
25. Ward KR. The microcirculation: linking trauma and coagulopathy. Transfusion 2013 ; 53 : 38-47.
26. Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Lösche W. HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care 2009 ; 13 : R208.
27. Haas T, Korte W, Spielmann N, Mauch J, Madjdpour C, Schmugge M, Weiss M. Perioperative course of FXIII in children undergoing major surgery. Paediatr Anaesth 2012 ; 22 : 641-6.
28. L auer P, M etzner HJ, Z ettlmeissl G, Li M, S mith A G, Lathe R, Dickneite G. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost 2002 ; 88 : 967-74. (Pubitemid 36024124)
29. Nielsen V G, Kirklin J K, Hoogendoorn H, Ellis TC, Holman WL. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagul Fibrinolysis 2007 ; 18 : 145-50. (Pubitemid 46232835)
30. Theusinger OM, B aulig W, A smis LM, S eifert B, S pahn DR. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 2010 ; 104 : 385-91.
31. Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008 ; 14 : 1190-200.
32. Weber CF, J ambor C, M arquardt M, Görlinger K, Zwissler B. Thrombelastometric detection of factor XIII deficiency. Anaesthesist 2008 ; 57 : 487-90.
33. Genét GF, Ostrowski SR, Sørensen A M, Johansson P. Detection of tPA-induced hyperfibrinolysis in whole blood by rapidTEG, KaolinTEG, and functional FibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost 2012 ; 18 : 638-44.
34. Bolliger D, Szlam F, Levy JH, Molinaro RJ, T anaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010 ; 104 : 318-25.
35. Huang YH, Liu C C, Wang S T, Lei H Y, Liu H L, Lin YS, Wu HL, Yeh TM. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 2001 ; 63 : 247-51.
36. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013 ; 11 : 307-14.
37. Schlimp C J, C adamuro J, S olomon C, R edl H, Schöchl H. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus 2012 ; 13 : 1 - 9.
38. Stumph MJ, Weir FW, Noall MW. Comparison of blood and brain toluene concentrations and circulating triglyceride levels resulting from acute and repeated exposures in rats. Am Ind Hyg Assoc J 1985 ; 46 : 244-50. (Pubitemid 15039576)
39. Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, Spahn DR. Low-and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 2000 ; 93 : 1231-7.
40. Jonville-Bera AP, Autret-Leca E, Gruel Y. A cquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch. N Engl J Med 2001 ; 345 : 622-3. (Pubitemid 32772113)
41. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation. Acta Anaesthesiol Taiwan 2009 ; 47 : 71-8.
42. Innerhofer P, Fries D, M argreiter J, K lingler A, Kühbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002 ; 95 : 858-65.
43. Nielsen VG. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIIImediated fibrin polymer crosslinking. J Surg Res 2006 ; 132 : 17-22.
44. Darlington D N, Kremenevskiy I, Pusateri AE, Scherer M R, Fedyk CG, Kheirabaldi BS, Delgado AV, Dubick MA. Effects of in vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood. Int J Burns Trauma 2012 ; 2 : 42-50.
45. Chowdary P, Saayman A G, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004 ; 125 : 69-73. (Pubitemid 38453280)
46. Stief T W. Therapeutic human albumins trigger plasmatic thrombin generation. Hemostasis Laboratory 2008 ; 1 : 185-92.
47. Schols SE, LancéMD, Feijge MA, D amoiseaux J, Marcus MA, Hamulyák K, Ten Cate H, Heemskerk JW, van Pampus EC. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 2010 ; 103 : 318-28.
48. Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. Scand J Clin Lab Invest 2012 ; 72 : 121-8.
49. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012 ; 10 : 1342-51.
50. Ternström L, Radulovic V, Karlsson M, Baghaei F, Hyllner M, Bylock A, Hansson KM, Jeppsson A. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res 2010 ; 126 : 128-33.
51. Genét G F, J ohansson P I, Meyer M A, Sølbeck S, Sørensen AM, Larsen CF, Welling KL, Windeløv NA, Rasmussen LS, Ostrowski SR. Trauma-induced coagulopathy: standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury. J Neurotrauma 2013 ; 30 : 301-6.
52. Gerlach R, R aabe A, Z immermann M, S iegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000 ; 54 : 260-4.
53. Gertler R, M artin K, H apfelmeier A, T assani-Prell P, Braun S, Wiesner G. The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery. Paediatr Anaesth 2013 May 13. doi: 10.1111/pan.12193. [Epub ahead of print]
54. Idris Z, Muzaimi M, Hussin S, Mahmood WH, Abdullah WZ. Association of perioperative factor XIII activity levels and other haemostatic markers with the risk of postoperative intracranial haematoma in a selected cohort of neurosurgical patients. Acta Neurochir 2012 ; 154 : 887-93.
55. Kapusta P, Wypasek E, Natorska J, Grudzien G, Sobczyk D, Sadowski J, Undas A. Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease. Thromb Haemost 2012 ; 108 : 1172-9.
56. Levy JH, Greenberg C. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2013 ; 53 : 1120-31.
57. Lawrie AS, Green L, M ackie IJ, L iesner R, Machin SJ, Peyvandi F. Factor XIII - an under diagnosed deficiency - are we using the right assays? J Thromb Haemost 2010 ; 8 : 2478-82.
58. Innerhofer P, Kienast J. Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol 2010 ; 24 : 1-14.
59. Vrettou C S, Stavrinou L C, Halikias S, Kyriakopoulou M, Kollias S, Stranjalis G, Koutsoukou A. Factor XIII defi- ciency as a potential cause of supratentorial haemorrhage after posterior fossa surgery. Acta Neurochir 2010 ; 152 : 529-32.
60. Johansson PI, Jacobsen N, Viuff D, Olsen EH, Rojkjaer R, Andersen S, Petersen LC, Kjalke M. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers. Br J Haematol 2008 ; 143 : 559-69.
61. Veldman A, Neuhaeuser C, Akintuerk H, Thul J, Gehron J, Schranz D, Michel-Behnke I. rFVIIa in the treatment of persistenThemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth 2007 ; 17 : 1176-81. (Pubitemid 350059105)
62. Hildebrandt B, M achotta A, R iess H, K erner S, Ahlers O, Haberl H, Dörken B, Kerner T. Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery - a pilot study comparing coagulation profiles in infants younger than 12 months. Thromb Haemost 2007 ; 98 : 172-7. (Pubitemid 47074193)
63. Ogawa S, Szlam F, Ohnishi T, Molinaro R J, Hosokawa K, Tanaka KA. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost 2011 ; 106 : 1215-23.